Plus Therapeutics PSTV Q2 2025 earnings
Reported August 14, 2025 · After market close
Revenue$1.4MMiss by $96.3K
EPS-$0.01Beat by $0.08
Revenue estimate$1.5M
EPS estimate-$0.09
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$1.1M
EPS estimate-$0.88
Versus estimates
Revenue
Diluted EPS
Ask the moment Plus Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Plus Therapeutics report Q2 2025 earnings?
- Plus Therapeutics (PSTV) reported Q2 2025 earnings on August 14, 2025 after market close.
- What were Plus Therapeutics's Q2 2025 revenue and EPS?
- Plus Therapeutics reported revenue of $1.4M and eps of $-0.01 for Q2 2025.
- Did Plus Therapeutics beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $1.5M by $96.3K. EPS beat the consensus estimate of $-0.09 by $0.08.
- How did Plus Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 8.7% from $1.3M a year earlier and eps grew 98.6% from $-0.71.
- Where can I find Plus Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-108874) directly on SEC EDGAR. The filing index links above go to sec.gov.